## Management of Tinea Corporis **Key Point:** Dermatophyte infections in immunocompetent individuals do NOT require lifelong prophylaxis. They respond well to finite courses of topical or systemic antifungals with appropriate lifestyle modifications. ### Correct Management Principles **First-line therapy for localized disease:** - Topical azoles (miconazole, clotrimazole, ketoconazole) or allylamines (terbinafine cream) - Apply twice daily for 2–4 weeks - Continue for 1–2 weeks after clinical resolution to prevent relapse **Indications for systemic therapy:** - Extensive involvement (>10% BSA) - Failure of topical therapy after 4 weeks - Involvement of hair-bearing areas (tinea barbae) - Immunocompromised host **Systemic agents:** | Agent | Dose | Duration | Notes | |-------|------|----------|-------| | Terbinafine | 250 mg daily | 2–4 weeks | Faster action, preferred | | Griseofulvin | 500 mg–1 g daily | 4–6 weeks | Older agent, longer duration | | Itraconazole | 200 mg daily | 2–4 weeks | Pulse therapy option | **High-Yield:** Recurrence rates in immunocompetent individuals are ~10–20% even after successful treatment — due to reinfection from environment or fomites, NOT treatment failure. Prophylaxis is NOT indicated. ### Why Option 2 Is Wrong **Clinical Pearl:** Lifelong prophylaxis is: - **NOT indicated** in immunocompetent individuals - **Reserved for** severely immunocompromised patients (CD4 <50 cells/μL in HIV/AIDS) or those with recurrent, severe infections - **Impractical and unnecessary** in the general population Recurrence prevention relies on: 1. Adequate initial treatment (complete course) 2. Environmental decontamination (washing clothes, bedding) 3. Lifestyle modifications (moisture control, hygiene) 4. Avoiding shared bathing areas and fomites ## Mnemonic: TREAT-R **T**opical for localized, **R**educed area, **E**xtensive → **A**ntifungal systemic, **T**reatment duration 2–4 weeks, **R**ecurrence prevention via hygiene (not prophylaxis) **Warning:** Do not confuse tinea corporis (which rarely recurs if treated adequately) with onychomycosis (which has high recurrence and may warrant prophylaxis in select cases).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.